Cargando…

COVID-19 sequelae among competitive athletes: a systematic review: Valerio Flavio Corona

BACKGROUND: During the COVID-19 pandemic, several professional athletes from different sports were infected by SARS-CoV-2. The aim of this systematic review was to evaluate the currently available scientific evidence regarding the cardiological, pulmonary, psychological, and combined sequelae, in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Corona, VF, Gualano, MR, Valz Gris, A, Rossi, MR, Regazzi, L, Ricciardi, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620034/
http://dx.doi.org/10.1093/eurpub/ckac131.403
_version_ 1784821305753731072
author Corona, VF
Gualano, MR
Valz Gris, A
Rossi, MR
Regazzi, L
Ricciardi, W
author_facet Corona, VF
Gualano, MR
Valz Gris, A
Rossi, MR
Regazzi, L
Ricciardi, W
author_sort Corona, VF
collection PubMed
description BACKGROUND: During the COVID-19 pandemic, several professional athletes from different sports were infected by SARS-CoV-2. The aim of this systematic review was to evaluate the currently available scientific evidence regarding the cardiological, pulmonary, psychological, and combined sequelae, in professional athletes. METHODS: The present systematic review was performed following the PRISMA statements, thereby searching on 3 databases: PubMed, ISI Web of Science, Scopus. Primary studies published between January 2020 and March 2022, investigating symptomatic and instrumental sequelae in competitive athletes after COVID-19 infection, were included. RESULTS: A total of 1,957 articles were screened, finally 18 were included (6 cohort studies, 2 case-control studies and 10 cross-sectional studies). Studies’ sample size ranged from a minimum of 12 to 1908 athletes playing different sports. In addition, the studies examined the following type of sequelae: 12 cardiological, 2 psychological, 1 pulmonary and 3 combined. Regarding the cardiological field, the prevalence of anomalies in instrumental examinations ranged 0-27.89% for first level tests (echocardiography, electrocardiogram, troponin), and 0-6.21% for second level tests (cardiac magnetic resonance). The prevalence of myocarditis and pericarditis in the athletes ranged from 0 to 3.33%, whereby the prevalence of myocarditis was in the range 0-2.32% and that of pericarditis in the range 0-2.22%. CONCLUSIONS: The results show that post SARS-CoV-2 infection cardiac sequelae have a quite low prevalence among competitive athletes included in our review, but it would be important to set up a gradual and continuous testing approach to preserve sports performance. Public health framework, such as vaccination campaign, is important both at European and international level in order to address potential consequences of infectious diseases among competitive athletes. KEY MESSAGES: • It is important to monitor all COVID-19 sequelae in European competitive athletes playing different sports. • Considering anti-COVID-19 vaccination in competitive athletes as an important preventive measure, to limit the circulation of the virus and the physical consequences that may occur.
format Online
Article
Text
id pubmed-9620034
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96200342022-11-04 COVID-19 sequelae among competitive athletes: a systematic review: Valerio Flavio Corona Corona, VF Gualano, MR Valz Gris, A Rossi, MR Regazzi, L Ricciardi, W Eur J Public Health Poster Displays BACKGROUND: During the COVID-19 pandemic, several professional athletes from different sports were infected by SARS-CoV-2. The aim of this systematic review was to evaluate the currently available scientific evidence regarding the cardiological, pulmonary, psychological, and combined sequelae, in professional athletes. METHODS: The present systematic review was performed following the PRISMA statements, thereby searching on 3 databases: PubMed, ISI Web of Science, Scopus. Primary studies published between January 2020 and March 2022, investigating symptomatic and instrumental sequelae in competitive athletes after COVID-19 infection, were included. RESULTS: A total of 1,957 articles were screened, finally 18 were included (6 cohort studies, 2 case-control studies and 10 cross-sectional studies). Studies’ sample size ranged from a minimum of 12 to 1908 athletes playing different sports. In addition, the studies examined the following type of sequelae: 12 cardiological, 2 psychological, 1 pulmonary and 3 combined. Regarding the cardiological field, the prevalence of anomalies in instrumental examinations ranged 0-27.89% for first level tests (echocardiography, electrocardiogram, troponin), and 0-6.21% for second level tests (cardiac magnetic resonance). The prevalence of myocarditis and pericarditis in the athletes ranged from 0 to 3.33%, whereby the prevalence of myocarditis was in the range 0-2.32% and that of pericarditis in the range 0-2.22%. CONCLUSIONS: The results show that post SARS-CoV-2 infection cardiac sequelae have a quite low prevalence among competitive athletes included in our review, but it would be important to set up a gradual and continuous testing approach to preserve sports performance. Public health framework, such as vaccination campaign, is important both at European and international level in order to address potential consequences of infectious diseases among competitive athletes. KEY MESSAGES: • It is important to monitor all COVID-19 sequelae in European competitive athletes playing different sports. • Considering anti-COVID-19 vaccination in competitive athletes as an important preventive measure, to limit the circulation of the virus and the physical consequences that may occur. Oxford University Press 2022-10-25 /pmc/articles/PMC9620034/ http://dx.doi.org/10.1093/eurpub/ckac131.403 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Displays
Corona, VF
Gualano, MR
Valz Gris, A
Rossi, MR
Regazzi, L
Ricciardi, W
COVID-19 sequelae among competitive athletes: a systematic review: Valerio Flavio Corona
title COVID-19 sequelae among competitive athletes: a systematic review: Valerio Flavio Corona
title_full COVID-19 sequelae among competitive athletes: a systematic review: Valerio Flavio Corona
title_fullStr COVID-19 sequelae among competitive athletes: a systematic review: Valerio Flavio Corona
title_full_unstemmed COVID-19 sequelae among competitive athletes: a systematic review: Valerio Flavio Corona
title_short COVID-19 sequelae among competitive athletes: a systematic review: Valerio Flavio Corona
title_sort covid-19 sequelae among competitive athletes: a systematic review: valerio flavio corona
topic Poster Displays
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620034/
http://dx.doi.org/10.1093/eurpub/ckac131.403
work_keys_str_mv AT coronavf covid19sequelaeamongcompetitiveathletesasystematicreviewvalerioflaviocorona
AT gualanomr covid19sequelaeamongcompetitiveathletesasystematicreviewvalerioflaviocorona
AT valzgrisa covid19sequelaeamongcompetitiveathletesasystematicreviewvalerioflaviocorona
AT rossimr covid19sequelaeamongcompetitiveathletesasystematicreviewvalerioflaviocorona
AT regazzil covid19sequelaeamongcompetitiveathletesasystematicreviewvalerioflaviocorona
AT ricciardiw covid19sequelaeamongcompetitiveathletesasystematicreviewvalerioflaviocorona